Applied Genetic Technologies Corporation Expands Its Clinical and Regulatory Expertise with Appointment of Jeffrey Chulay M.D. as Vice President and Chief Medical Officer

Published: Jul 09, 2007

ALACHUA, Fla.--(BUSINESS WIRE)--AGTC (Applied Genetic Technologies Corporation), a privately held clinical stage gene therapy company, is pleased to announce that Dr. Jeffrey Chulay has joined the company as Chief Medical Officer and Vice President of Regulatory Affairs.

Back to news